Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis. Brück W, Zamvil SS Expert Rev Clin Pharmacol. 2012 May; 5(3):245-56. PMID: 22697588. Abstract CommentRecommendBookmarkWatch